Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Langenbeck's Archives of Surgery
Published in: Langenbeck's Archives of Surgery 2/2012

01-02-2012 | Review Article

Mesh biocompatibility: effects of cellular inflammation and tissue remodelling

Authors: Karsten Junge, Marcel Binnebösel, Klaus T. von Trotha, Raphael Rosch, Uwe Klinge, Ulf P. Neumann, Petra Lynen Jansen

Published in: Langenbeck's Archives of Surgery | Issue 2/2012

Login to get access

Abstract

Mesh biocompatibility is basically determined by the foreign body reaction (FBR). In contrast to physiological wound healing and scar formation, the FBR at the host-tissue/biomaterial interface is present for the lifetime of the medical device. The cellular interactions at the mesh/tissue interface proceed over time ending up in a chronic inflammatory process. The time course of the FBR has been studied extensively and consists of three crucial steps that are protein absorption, cell recruitment and, finally, fibrotic encapsulation and extracellular matrix formation. Each of these steps involves a complex cascade of immune modulators including soluble mediators and various cell types. Recent research has focused on the cellular and molecular interactions of the distinct phases of the FBR offering a new basis for therapeutical strategies. The highly dynamic process of the FBR is considerably influenced by the biomaterial composition. Modifications of the type of polymer, the material weight, the filament structure and the pore size are realized and have substantial effects on the in vivo biocompatibility. Moreover, modern mesh technology aims to utilize the available implants as carrier systems for bioactive drugs. Studies in animal models account for the efficiency of these drugs that aim to reduce mesh-related infections or to minimize FBR by influencing inflammation or extracellular matrix remodelling. A thorough understanding of the molecular mechanisms of FBR provides a sophisticated background for the development of new biomaterials at least as carrier systems for bioactive reagents to reduce inflammation and to improve clinical outcome.
Literature
1.
2.
3.
Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2001) Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia 5:142–147PubMedCrossRef
4.
Lange B, Langer C, Markus PM, Becker H (2003) Mesh penetration of the sigmoid colon following a transabdominal preperitoneal hernia repair. Surg Endosc 17:157PubMedCrossRef
5.
Conze J, Rosch R, Klinge U, Weiss C, Anurov M, Titkowa S, Oettinger A, Schumpelick V (2004) Polypropylene in the intra-abdominal position: influence of pore size and surface area. Hernia 8:365–372PubMedCrossRef
6.
Conze J, Klinge U, Schumpelick V (2006) Evidenzbasierte laparoskopische Chirurgie - Narbenhernie. Viszeralchirurgie 41:246–252CrossRef
7.
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382PubMedCrossRef
8.
Robinson TN, Clarke JH, Schoen J, Walsh MD (2005) Major mesh-related complications following hernia repair: events reported to the food and drug administration. Surg Endosc 19:1556–1560PubMedCrossRef
9.
Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, de Lange D, Fortelny R, Heikkinen T, Kingsnorth A, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Miserez M (2009) European Hernia society guidelines on the treatment of inguinal hernia in adult patients. Hernia 13:343–403PubMedCrossRef
10.
11.
Usher F, JL O, Tuttle LJ (1958) Use of Marlex mesh in the repair of incisional hernias. Am Surg 24:969–974PubMed
12.
Klinge U, Junge K, Stumpf M, AP AP, Klosterhalfen B (2002) Functional and morphological evaluation of a low-weight, monofilament polypropylene mesh for hernia repair. J Biomed Mater Res 63:129–136PubMedCrossRef
13.
Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze J, Schumpelick V (2002) Impact of polymer pore size on the interface scar formation in a rat model. J Surg Res 103:208–214PubMedCrossRef
14.
Klinge U, Klosterhalfen B, Conze J, Limberg W, Obolenski B, Ottinger AP, Schumpelick V (1998) Modified mesh for hernia repair that is adapted to the physiology of the abdominal wall. Eur J Surg 164:951–960PubMedCrossRef
15.
Horstmann R, Hellwig M, Classen C, Rottgermann S, Palmes D (2006) Impact of polypropylene amount on functional outcome and quality of life after inguinal hernia repair by the TAPP procedure using pure, mixed, and titanium-coated meshes. World J Surg 30:1742–1749PubMedCrossRef
16.
O'dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G (2005) Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 92:166–170PubMedCrossRef
17.
Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen TJ (2006) Three-year results of a randomized clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 93:1056–1059PubMedCrossRef
18.
Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R (2007) Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 194:394–400PubMedCrossRef
19.
Conze J, Krones CJ, Schumpelick V, Klinge U (2007) Incisional hernia: challenge of re-operations after mesh repair. Langenbecks Arch Surg 392:453–457PubMedCrossRef
20.
Conze J, Binnebosel M, Junge K, Schumpelick V (2010) Incisional hernia—how do I do it? Standard surgical approach. Chirurg 81:192–200PubMedCrossRef
21.
22.
Klinge U, Krones CJ (2005) Can we be sure that the meshes do improve the recurrence rates? Hernia 9:1–2PubMedCrossRef
23.
Nilsson B, Korsgren O, Lambris JD, Ekdahl KN (2010) Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol 31:32–38PubMedCrossRef
24.
Morais JM, Papadimitrakopoulos F, Burgess DJ (2010) Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J 12:188–196PubMedCrossRef
25.
Junge K, Rosch R, Klinge U, Krones C, Klosterhalfen B, Mertens PR, Lynen P, Kunz D, Preiss A, Peltroche-Llacsahuanga H, Schumpelick V (2005) Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis. Biomaterials 26:787–793PubMedCrossRef
26.
Franz MG, Kuhn MA, Nguyen K, Wang X, Ko F, Wright TE, Robson MC (2001) Transforming growth factor beta(2) lowers the incidence of incisional hernias. J Surg Res 97:109–116PubMedCrossRef
27.
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100PubMedCrossRef
28.
Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ (2005) Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 11:1–18PubMedCrossRef
29.
Jenney CR, Anderson JM (2000) Adsorbed IgG: a potent adhesive substrate for human macrophages. J Biomed Mater Res 50:281–290PubMedCrossRef
30.
Jenney CR, Anderson JM (2000) Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 49:435–447PubMedCrossRef
31.
Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B (2002) C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 168:5786–5791PubMed
32.
Tengvall P, Askendal A, Lundstrom I (2001) I Ellipsometric in vitro studies on the activation of complement by human immunoglobulins M and G after adsorption to methylated silicon. Colloids Surf B Biointerfaces 20:51–62PubMedCrossRef
33.
Vroman L, Adams AL, Klings M (1971) Interactions among human blood proteins at interfaces. Fed Proc 30:1494–1502PubMed
34.
Xu LC, Siedlecki CA (2007) Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials 28:3273–3283PubMedCrossRef
35.
Brash JL, Lyman DJ (1969) Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces. J Biomed Mater Res 3:175–189PubMedCrossRef
36.
Krishnan A, Cha P, Liu YH, Allara D, Vogler EA (2006) Interfacial energetics of blood plasma and serum adsorption to a hydrophobic self-assembled monolayer surface. Biomaterials 27:3187–3194PubMedCrossRef
37.
Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) The role of complement in biomaterial-induced inflammation. Mol Immunol 44:82–94PubMedCrossRef
38.
Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25:5681–5703PubMedCrossRef
39.
Broughton G, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117:12S–34SPubMedCrossRef
40.
Rhodes NP, Hunt JA, Williams DF (1997) Macrophage subpopulation differentiation by stimulation with biomaterials. J Biomed Mater Res 37:481–8PubMedCrossRef
41.
Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610–621PubMedCrossRef
42.
Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P (2004) The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165:2157–2166PubMedCrossRef
43.
Jones JA, Chang DT, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM (2007) Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 83:585–596PubMed
44.
Esche C, Stellato C, Beck LA (2005) Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615–628PubMedCrossRef
45.
Brodbeck WG, Colton E, Anderson JM (2003) Effects of adsorbed heat labile serum proteins and fibrinogen on adhesion and apoptosis of monocytes/macrophages on biomaterials. J Mater Sci Mater Med 14:671–675PubMedCrossRef
46.
McNally AK, Anderson JM (1994) Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci USA 91:10119–10123PubMedCrossRef
47.
Gallant ND, Garcia AJ (2007) Model of integrin-mediated cell adhesion strengthening. J Biomech 40:1301–1309PubMedCrossRef
48.
49.
50.
McNally AK, Anderson JM (2002) Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 160:621–630PubMedCrossRef
51.
Rose DM, Alon R, Ginsberg MH (2007) Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev 218:126–134PubMedCrossRef
52.
Damsky CH, Ilic D (2002) Integrin signaling: it's where the action is. Curr Opin Cell Biol 14:594–602PubMedCrossRef
53.
54.
Brodbeck WG, Patel J, Voskerician G, Christenson E, Shive MS, Nakayama Y, Matsuda T, Ziats NP, Anderson JM (2002) Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci USA 99:10287–10292PubMedCrossRef
55.
DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM (1997) Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 158:3385–3390PubMed
56.
Helming L, Gordon S (2007) Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 37:33–42PubMedCrossRef
57.
Jones JA, Dadsetan M, Collier TO, Ebert M, Stokes KS, Ward RS, Hiltner PA, Anderson JM (2004) Macrophage behavior on surface-modified polyurethanes. J Biomater Sci Polym Ed 15:567–584PubMedCrossRef
58.
59.
Henson PM (1971) The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol 107:1535–1546PubMed
60.
Henson PM (1971) The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol 107:1547–1557PubMed
61.
Cozad MJ, Grant DA, Bachman SL, Grant DN, Ramshaw BJ, Grant SA (2010) Materials characterization of explanted polypropylene, polyethylene terephthalate, and expanded polytetrafluoroethylene composites: spectral and thermal analysis. J Biomed Mater Res B Appl Biomater 94:455–462PubMed
62.
Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599–607PubMedCrossRef
63.
Li AG, Quinn MJ, Siddiqui Y, Wood MD, Federiuk IF, Duman HM, Ward WK (2007) Elevation of transforming growth factor beta (TGFbeta) and its downstream mediators in subcutaneous foreign body capsule tissue. J Biomed Mater Res A 82:498–508PubMed
64.
Higgins DM, Basaraba RJ, Hohnbaum AC, Lee EJ, Grainger DW, Gonzalez-Juarrero M (2009) Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 175:161–170PubMedCrossRef
65.
Ward WK, Li AG, Siddiqui Y, Federiuk IF, Wang XJ (2008) Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. J Biomater Sci Polym Ed 19:1065–1072PubMedCrossRef
66.
Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163–176PubMed
67.
Xue M, Le NT, Jackson CJ (2006) Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets 10:143–155PubMedCrossRef
68.
Le NT, Xue M, Castelnoble LA, Jackson CJ (2007) The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 12:1475–1487PubMedCrossRef
69.
Ravi A, Garg P, Sitaraman SV (2007) Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm Bowel Dis 13:97–107PubMedCrossRef
70.
Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839PubMedCrossRef
71.
Jansen PL, Kever M, Rosch R, Krott E, Jansen M, Alfonso-Jaume A, Dooley S, Klinge U, Lovett DH, Mertens PR (2007) Polymeric meshes induce zonal regulation of matrix metalloproteinase-2 gene expression by macrophages and fibroblasts. FASEB J 21:1047–1057PubMedCrossRef
72.
Luttikhuizen DT, Harmsen MC, Van Luyn MJ (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12:1955–1970PubMedCrossRef
73.
Miller KM, Anderson JM (1989) In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers. J Biomed Mater Res 23:911–930PubMedCrossRef
74.
Miller KM, Rose-Caprara V, Anderson JM (1989) Generation of IL-1-like activity in response to biomedical polymer implants: a comparison of in vitro and in vivo models. J Biomed Mater Res 23:1007–1026PubMedCrossRef
75.
Junge K, Klinge U, Prescher A, Giboni P, Niewiera M, Schumpelick V (2001) Elasticity of the anterior abdominal wall and impact for reparation of incisional hernias using mesh implants. Hernia 5:113–118PubMedCrossRef
76.
Liebert TC, Chartoff RP, Cosgrove SL, McCuskey RS (1976) Subcutaneous implants of polypropylene filaments. J Biomed Mater Res 10:939–951PubMedCrossRef
77.
Mary C, Marois Y, King MW, Laroche G, Douville Y, Martin L, Guidoin R (1998) Comparison of the in vivo behavior of polyvinylidene fluoride and polypropylene sutures used in vascular surgery. ASAIO J 44:199–206PubMedCrossRef
78.
Vinard E, Eloy R, Descotes J, Brudon JR, Guidicelli H, Magne JL, Patra P, Berruet R, Huc A, Chauchard J (1988) Stability of performances of vascular prostheses retrospective study of 22 cases of human implanted prostheses. J Biomed Mater Res 22:633–648PubMedCrossRef
79.
Maarek JM, Guidoin R, Aubin M, Prud'homme RE (1984) Molecular weight characterization of virgin and explanted polyester arterial prostheses. J Biomed Mater Res 18:881–894PubMedCrossRef
80.
Berger K, Suavage L (1980) Late fiber deterioration in Dacron arterial grafts. Ann Surg 193:477–491
81.
Riepe G, Loos J, Imig H, Schroder A, Schneider E, Petermann J, Rogge A, Ludwig M, Schenke A, Nassutt R, Chakfe N, Morlock M (1997) Long-term in vivo alterations of polyester vascular grafts in humans. Eur J Vasc Endovasc Surg 13:540–548PubMedCrossRef
82.
van der Lei B, Simmermacher RKJ, van Schilfgaarde R (1989) Expanded polytetrafluorethylene patch for the repair of large abdominal wall defects. Br J Surg 76:803–5PubMedCrossRef
83.
Bellon JM, Contreras LA, Bujan J (2000) Ultrastructural alterations of polytetrafluoroethylene prostheses implanted in abdominal wall provoked by infection: clinical and experimental study. World J Surg 24:528–531PubMedCrossRef
84.
Bellon JM, Contreras LA, Bujan J, Pascual G, Carrera-San Martin A (1999) Effect of relaparotomy through previously integrated polypropylene and polytetrafluoroethylene experimental implants in the abdominal wall. J Am Coll Surg 188:466–472PubMedCrossRef
85.
Klinge U, Klosterhalfen B, Ottinger AP, Junge K, Schumpelick V (2002) PVDF as a new polymer for the construction of surgical meshes. Biomaterials 23:3487–3493PubMedCrossRef
86.
Urban E, King MW, Guidoin R, Laroche G, Marois Y, Martin L, Cardou A, Douville Y (1994) Why make monofilament sutures out of polyvinylidene fluoride? ASAIO J 40:145–156PubMed
87.
Conze J, Junge K, Weiss C, Anurov M, Oettinger A, Klinge U, Schumpelick V (2008) New polymer for intra-abdominal meshes–PVDF copolymer. J Biomed Mater Res B Appl Biomater 87:321–328PubMed
88.
Junge K, Binnebosel M, Rosch R, Jansen M, Kammer D, Otto J, Schumpelick V, Klinge U (2009) Adhesion formation of a polyvinylidenfluoride/polypropylene mesh for intra-abdominal placement in a rodent animal model. Surg Endosc 23:327–333PubMedCrossRef
89.
Klosterhalfen B, Junge K, Klinge U (2005) The lightweight and large porous mesh concept for hernia repair. Expert Rev Med Devices 2:103–117PubMedCrossRef
90.
Weyhe D, Schmitz I, Belyaev O, Grabs R, Muller KM, Uhl W, Zumtobel V (2006) Experimental comparison of monofile light and heavy polypropylene meshes: less weight does not mean less biological response. World J Surg 30:1586–1591PubMedCrossRef
91.
Weyhe D, Belyaev O, Muller C, Meurer K, Bauer KH, Papapostolou G, Uhl W (2007) Improving outcomes in hernia repair by the use of light meshes–a comparison of different implant constructions based on a critical appraisal of the literature. World J Surg 31:234–244PubMedCrossRef
92.
Bellon JM, Jurado F, Garcia-Honduvilla N, Lopez R, Carrera-San Martin A, Bujan J (2002) The structure of a biomaterial rather than its chemical composition modulates the repair process at the peritoneal level. Am J Surg 184:154–159PubMedCrossRef
93.
Muhl T, Binnebosel M, Klinge U, Goedderz T (2008) New objective measurement to characterize the porosity of textile implants. J Biomed Mater Res B Appl Biomater 84:176–183PubMed
94.
Eichhorn SJ, Sampson WW (2005) Statistical geometry of pores and statistics of porous nanofibrous assemblies. J R Soc Interface 2:309–318PubMedCrossRef
95.
Clowes AW, Zacharias RK, Kirkman TR (1987) Early endothelial coverage of synthetic arterial grafts: porosity revisited. Am J Surg 153:501–504PubMedCrossRef
96.
Tsukada H, Osada H (2004) Experimental study of a new tracheal prosthesis: pored Dacron tube. J Thorac Cardiovasc Surg 127:877–884PubMedCrossRef
97.
Frosch KH, Barvencik F, Lohmann CH, Viereck V, Siggelkow H, Breme J, Dresing K, Sturmer KM (2002) Migration, matrix production and lamellar bone formation of human osteoblast-like cells in porous titanium implants. Cells Tissues Organs 170:214–227PubMedCrossRef
98.
Zhang Y, Xu HH, Takagi S, Chow LC (2006) In-situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci Mater Med 17:437–445PubMedCrossRef
99.
Karageorgiou V, Kaplan D (2005) Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474–5491PubMedCrossRef
100.
Cooper JA, Lu HH, Ko FK, Freeman JW, Laurencin CT (2005) Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials 26:1523–1532PubMedCrossRef
101.
Bobyn JD, Stackpool GJ, Hacking SA, Tanzer M, Krygier JJ (1999) Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg Br 81:907–914PubMedCrossRef
102.
Ayers RA, Simske SJ, Nunes CR, Wolford LM (1998) Long-term bone ingrowth and residual microhardness of porous block hydroxyapatite implants in humans. J Oral Maxillofac Surg 56:1297–1301PubMedCrossRef
103.
Eggli PS, Muller W, Schenk RK (1988) Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop Relat Res 127–138
104.
Deng X, Guidoin R (2000) Alternative blood conduits: assessment of whether the porosity of synthetic prostheses is the key to long-term biofunctionality. Med Biol Eng Comput 38:219–225PubMedCrossRef
105.
Bragdon CR, Burke D, Lowenstein JD, O'Connor DO, Ramamurti B, Jasty M, Harris WH (1996) Differences in stiffness of the interface between a cementless porous implant and cancellous bone in vivo in dogs due to varying amounts of implant motion. J Arthroplasty 11:945–951PubMedCrossRef
106.
Zellin G, Linde A (1996) Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials 17:695–702PubMedCrossRef
107.
Bertheville B (2006) Porous single-phase NiTi processed under Ca reducing vapor for use as a bone graft substitute. Biomaterials 27:1246–1250PubMedCrossRef
108.
Martakos P, Karwoski T (1995) Healing characteristics of hybrid and conventional polytetrafluoroethylene vascular grafts. ASAIO J 41:M735–M741PubMedCrossRef
109.
Akers DL, Du YH, Kempczinski RF (1993) The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. J Vasc Surg 18:10–15PubMedCrossRef
110.
Saberski ER, Orenstein SB, Novitsky YW (2010) Anisotropic evaluation of synthetic surgical meshes. Hernia
111.
Binnebosel M, Rosch R, Junge K, Flanagan TC, Schwab R, Schumpelick V, Klinge U (2007) Biomechanical analyses of overlap and mesh dislocation in an incisional hernia model in vitro. Surgery 142:365–371PubMedCrossRef
112.
Klinge U, Junge K, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V (2002) Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacteria adherence, and the in vivo consequences in a rat model. J Biomed Mater Res 63:765–771PubMedCrossRef
113.
Engelsman AF, van Dam GM, van der Mei HC, Busscher HJ, Ploeg RJ (2010) In vivo evaluation of bacterial infection involving morphologically different surgical meshes. Ann Surg 251:133–137PubMedCrossRef
114.
Junge K, Klinge U, Rosch R, Klosterhalfen B, Schumpelick V (2002) Functional and morphologic properties of a modified mesh for Inguinal hernia repair. World J Surg 26:1472–1480PubMedCrossRef
115.
Rosch R, Junge K, Quester R, Klinge U, Klosterhalfen B, Schumpelick V (2003) Vypro II mesh in hernia repair: impact of polyglactin on long-term incorporation in rats. Eur Surg Res 35:445–450PubMedCrossRef
116.
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Gomez-Gil V, Pascual G, Bujan J (2008) Postimplant behavior of lightweight polypropylene meshes in an experimental model of abdominal hernia. J Invest Surg 21:280–287PubMedCrossRef
117.
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Bujan J (2007) Partially absorbable meshes for hernia repair offer advantages over nonabsorbable meshes. Am J Surg 194:68–74PubMedCrossRef
118.
Weyhe D, Belyaev O, Buettner G, Mros K, Mueller C, Meurer K, Papapostolou G, Uhl W (2008) In vitro comparison of three different mesh constructions. ANZ J Surg 78:55–60PubMedCrossRef
119.
Junge K, Rosch R, Krones CJ, Klinge U, Mertens PR, Lynen P, Schumpelick V, Klosterhalfen B (2005) Influence of polyglecaprone 25 (Monocryl) supplementation on the biocompatibility of a polypropylene mesh for hernia repair. Hernia 9:212–217PubMedCrossRef
120.
Otto J, Binnebosel M, Pietsch S, Anurov M, Titkova S, Ottinger AP, Jansen M, Rosch R, Kammer D, Klinge U (2010) Large-pore PDS mesh compared to small-pore PG mesh. J Invest Surg 23:190–196PubMedCrossRef
121.
Gruber-Blum S, Petter-Puchner AH, Brand J, Fortelny RH, Walder N, Oehlinger W, Koenig F, Redl H (2010) Comparison of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experimental model. Br J Surg
122.
Loury JN, Chevrel JP (1983) Treatment of ventral hernias. Simultaneous use of polyglactin 910 and dacron mesh (letter). Presse Méd 12(2116 issn):0755–4982
123.
Vries Reilingh TS, van Goor H, Koppe MJ, Bodegom ME, Hendriks T, Bleichrodt RP (2007) Interposition of polyglactin mesh does not prevent adhesion formation between viscera and polypropylene mesh. J Surg Res 140:27–30PubMedCrossRef
124.
Conze J, Junge K, Klinge U, Weiss C, Polivoda M, Oettinger AP, Schumpelick V (2005) Intraabdominal adhesion formation of polypropylene mesh. Influence of coverage of omentum and polyglactin. Surg Endosc 19:798–803PubMedCrossRef
125.
Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Gomez GV, Bujan J (2007) Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A 1:160–166
126.
Jacob BP, Hogle NJ, Durak E, Kim T, Fowler DL (2007) Tissue ingrowth and bowel adhesion formation in an animal comparative study: polypropylene versus proceed versus parietex composite. Surg Endosc 21:629–633PubMedCrossRef
127.
Judge TW, Parker DM, Dinsmore RC (2007) Abdominal wall hernia repair: a comparison of sepramesh and parietex composite mesh in a rabbit hernia model. J Am Coll Surg 204:276–281PubMedCrossRef
128.
Emans PJ, Schreinemacher MH, Gijbels MJ, Beets GL, Greve JW, Koole LH, Bouvy ND (2009) Polypropylene meshes to prevent abdominal herniation. Can stable coatings prevent adhesions in the long term? Ann Biomed Eng 37:410–418PubMedCrossRef
129.
Schreinemacher MH, Emans PJ, Gijbels MJ, Greve JW, Beets GL, Bouvy ND (2009) Degradation of mesh coatings and intraperitoneal adhesion formation in an experimental model. Br J Surg 96:305–313PubMedCrossRef
130.
van't RM, de Vos van Steenwijk PJ, Bonthuis F, Marquet RL, Steyerberg EW, Jeekel J, Bonjer HJ (2003) Prevention of adhesion to prosthetic mesh: comparison of different barriers using an incisional hernia model. Ann Surg 237:123–128CrossRef
131.
Vrijland WW, Bonthuis F, Steyerberg EW, Marquet RL, Jeekel J, Bonjer HJ (2000) Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc 14:960–963PubMedCrossRef
132.
Burger JW, Halm JA, Wijsmuller AR, ten Raa S, Jeekel J (2006) Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc 20:1320–1325PubMedCrossRef
133.
Chelala E, Debardemaeker Y, Elias B, Charara F, Dessily M, Alle JL (2010) Eighty-five redo surgeries after 733 laparoscopic treatments for ventral and incisional hernia: adhesion and recurrence analysis. Hernia 14:123–129PubMedCrossRef
134.
Wassenaar EB, Schoenmaeckers EJ, Raymakers JT, Rakic S (2010) Subsequent abdominal surgery after laparoscopic ventral and incisional hernia repair with an expanded polytetrafluoroethylene mesh: a single institution experience with 72 reoperations. Hernia 14:137–142PubMedCrossRef
135.
Zinther NB, Zeuten A, Marinovskij E, Haislund M, Friis-Andersen H (2010) Functional cine MRI and transabdominal ultrasonography for the assessment of adhesions to implanted synthetic mesh 5–7 years after laparoscopic ventral hernia repair. Hernia 14:499–504PubMedCrossRef
136.
Jenkins ED, Yom V, Melman L, Brunt LM, Eagon JC, Frisella MM, Matthews BD (2010) Prospective evaluation of adhesion characteristics to intraperitoneal mesh and adhesiolysis-related complications during laparoscopic re-exploration after prior ventral hernia repair. Surg Endosc 24:3002–3007PubMedCrossRef
137.
Shastri VP (2003) Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 4:331–337PubMedCrossRef
138.
Wisniewski N, Reichert M (2000) Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces 18:197–219PubMedCrossRef
139.
Shen M, Horbett TA (2001) The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 57:336–345PubMedCrossRef
140.
de Vos P, van Hoogmoed CG, de Haan BJ, Busscher HJ (2002) Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 62:430–437PubMedCrossRef
141.
de Vos P, Hoogmoed CG, Busscher HJ (2002) Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 60:252–259PubMedCrossRef
142.
Vercruysse KP, Prestwich GD (1998) Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 15:513–555PubMed
143.
Uchegbu IF, Schatzlein AG, Tetley L, Gray AI, Sludden J, Siddique S, Mosha E (1998) Polymeric chitosan-based vesicles for drug delivery. J Pharm Pharmacol 50:453–458PubMedCrossRef
144.
Borchard G, Junginger HE (2001) Modern drug delivery applications of chitosan. Adv Drug Deliv Rev 52:103PubMedCrossRef
145.
Sano A, Hojo T, Maeda M, Fujioka K (1998) Protein release from collagen matrices. Adv Drug Deliv Rev 31:247–266PubMedCrossRef
146.
Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55:1613–1629PubMedCrossRef
147.
Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu B, Schacht E (1998) In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 19:1677–1687PubMedCrossRef
148.
Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, Bogdanov B, Schacht E (1998) In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials 19:99–107PubMedCrossRef
149.
Athanasiou KA, Niederauer GG, Agrawal CM (1996) Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17:93–102PubMedCrossRef
150.
Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS (1995) Applications of biodegradable lactides and glycolides in podiatry. Clin Podiatr Med Surg 12:475–95PubMed
151.
Shive MS, Anderson JM (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24PubMedCrossRef
152.
Espadas-Torre C, Meyerhoff ME (1995) Thrombogenic properties of untreated and poly(ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ion-selective electrodes. Anal Chem 67:3108–3114PubMedCrossRef
153.
Paradossi G, Cavalieri F, Chiessi E, Spagnoli C, Cowman MK (2003) Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications. J Mater Sci Mater Med 14:687–691PubMedCrossRef
154.
Maruoka S, Matsuura T, Kawasaki K, Okamoto M, Yoshiaki H, Kodama M, Sugiyama M, Annaka M (2006) Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 31:599–606PubMedCrossRef
155.
Voskerician G, Jin J, White MF, Williams CP, Rosen MJ (2010) Effect of biomaterial design criteria on the performance of surgical meshes for abdominal hernia repair: a pre-clinical evaluation in a chronic rat model. J Mater Sci Mater Med 21:1989–1995PubMedCrossRef
156.
Schug-Pass C, Sommerer F, Tannapfel A, Lippert H, Kockerling F (2009) The use of composite meshes in laparoscopic repair of abdominal wall hernias: are there differences in biocompatibily?: experimental results obtained in a laparoscopic porcine model. Surg Endosc 23:487–495PubMedCrossRef
157.
Murphy JL, Vollenweider L, Xu F, Lee BP (2010) Adhesive performance of biomimetic adhesive-coated biologic scaffolds. Biomacromolecules
158.
Junge K, Rosch R, Anurov M, Titkova S, Ottinger A, Klinge U, Schumpelick V (2006) Modification of collagen formation using supplemented mesh materials. Hernia 10:492–497PubMedCrossRef
159.
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–82PubMedCrossRef
160.
Kumar S (1999) Chronic groin sepsis following tension-free inguinal hernioplasty [letter; comment]. Br J Surg 86:1482PubMed
161.
White TJ, Santos MC, Thompson JS (1998) Factors affecting wound complications in repair of ventral hernias. Am Surg 64:276–80PubMed
162.
Deysine M (1998) Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. Surg Clin North Am 78:1105–15PubMedCrossRef
163.
Taylor EW, Byrne DJ, Leaper DJ, Karran SJ, Browne MK, Mitchell KJ (1997) Antibiotic prophylaxis and open groin hernia repair. World J Surg 21:811–814PubMedCrossRef
164.
Rios A, Rodriguez JM, Munitiz V, Alcaraz P, Perez FD, Parrilla P (2001) Antibiotic prophylaxis in incisional hernia repair using a prosthesis. Hernia 5:148–152PubMedCrossRef
165.
Lazorthes F, Chiotasso P, Massip P, Materre JP, Sarkissian M (1992) Local antibiotic prophylaxis in inguinal hernia repair. Surg Gynecol Obstet 175:569–570PubMed
166.
Musella M, Guido A, Musella S (2001) Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg 167:130–132PubMedCrossRef
167.
168.
Pratesi C, Russo D, Dorigo W, Chiti E (2001) Antibiotic prophylaxis in clean surgery: vascular surgery. J Chemother 13(Spec No 1):123–128PubMed
169.
Murray WR (1984) Use of antibiotic-containing bone cement. Clin Orthop 89-95
170.
McQueen MM, Hughes SP, May P, Verity L (1990) Cefuroxime in total joint arthroplasty. Intravenous or in bone cement. J Arthroplasty 5:169–172PubMedCrossRef
171.
Gilbert AI, Felton LL (1993) Infection in inguinal hernia repair considering biomaterials and antibiotics [published erratum appears in Surg Gynecol Obstet 1993 Nov;177(5):528]. Surg Gynecol Obstet 177:126–130PubMed
172.
173.
Badiou W, Lavigne JP, Bousquet PJ, O'Callaghan D, Mares P, de Tayrac R (2010) In vitro and in vivo assessment of silver-coated polypropylene mesh to prevent infection in a rat model. Int Urogynecol J Pelvic Floor Dysfunct
174.
Franklin ME Jr, Gonzalez JJ Jr, Michaelson RP, Glass JL, Chock DA (2002) Preliminary experience with new bioactive prosthetic material for repair of hernias in infected fields. Hernia 6:171–174PubMedCrossRef
175.
Dubay DA, Wang X, Kuhn MA, Robson MC, Franz MG (2004) The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg 240:179–186PubMedCrossRef
176.
Robson MC, Dubay DA, Wang X, Franz MG (2004) Effect of cytokine growth factors on the prevention of acute wound failure. Wound Repair Regen 12:38–43PubMedCrossRef
177.
Korenkov M, Yuecel N, Koebke J, Schierholz J, Morsczeck C, Tasci I, Neugebauer EA, Nagelschmidt M (2005) Local administration of TGF-beta1 to reinforce the anterior abdominal wall in a rat model of incisional hernia. Hernia
178.
Orenstein SB, Saberski ER, Klueh U, Kreutzer DL, Novitsky YW (2010) Effects of mast cell modulation on early host response to implanted synthetic meshes. Hernia 14:511–516PubMedCrossRef
179.
Tang L, Jennings TA, Eaton JW (1998) Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 95:8841–8846PubMedCrossRef
180.
Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18:335–350PubMedCrossRef
181.
182.
Schaffer M, Bongartz M, Hoffmann W, Viebahn R (2006) Regulation of nitric oxide synthesis in wounds by IFN-gamma depends on TNF-alpha. J Invest Surg 19:371–379PubMedCrossRef
183.
184.
Park JY, Pillinger MH (2007) Interleukin-6 in the pathogenesis of rheumatoid arthritis. Bull NYU Hosp Jt Dis 65(Suppl 1):S4–10PubMed
185.
Mudter J, Neurath MF (2007) Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13:1016–1023PubMedCrossRef
186.
Di Vita G, D'Agostino P, Patti R, Arcara M, Caruso G, Davi V, Cillari E (2005) Acute inflammatory response after inguinal and incisional hernia repair with implantation of polypropylene mesh of different size. Langenbecks Arch Surg 390:306–311PubMedCrossRef
187.
Junge K, Binnebosel M, Rosch R, Otto J, Kammer D, Schumpelick V, Klinge U (2009) Impact of proinflammatory cytokine knockout on mesh integration. J Invest Surg 22:256–262PubMedCrossRef
188.
Junge K, Klinge U, Rosch R, Lynen P, Binnebosel M, Conze J, Mertens PR, Schwab R, Schumpelick, V (2007) Improved collagen type I/III ratio at the interface of gentamicin-supplemented polyvinylidenfluoride mesh materials. Langenbecks Arch Surg
189.
Binnebosel M, Ricken C, Klink CD, Junge K, Jansen M, Schumpelick V, Lynen JP (2010) Impact of gentamicin-supplemented polyvinylidenfluoride mesh materials on MMP-2 expression and tissue integration in a transgenic mice model. Langenbecks Arch Surg 395:413–420PubMedCrossRef
190.
Tekos A, Prodromaki E, Papadimou E, Pavlidou D, Tsambaos D, Drainas D (2003) Aminoglycosides suppress tRNA processing in human epidermal keratinocytes in vitro. Skin Pharmacol Appl Skin Physiol 16:252–258PubMedCrossRef
191.
Sacha PT, Zaremba ML, Jakoniuk P (1999) The influence of antibiotics on phagocytic and bacteriocidal activity of rabbit peritoneal macrophages stimulated by filtrates of cultured t-lymphocytes. Med Dosw Mikrobiol 51:399–412PubMed
192.
Keeling KM, Bedwell DM (2002) Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80:367–376PubMedCrossRef
193.
Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:1433–1441PubMedCrossRef
194.
Clancy JP, Bebok Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M, Lyrene R, Sorscher EJ, Bedwell DM (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163:1683–1692PubMed
195.
Wrzesniok D, Buszman E, Karna E, Nawrat P, Palka J (2002) Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur J Pharmacol 446:7–13PubMedCrossRef
196.
Asch HL, Farnham PJ (1978) Effects of gentamicin on trypsin, chymotrypsin, and collagenase. J Infect Dis 138:257–259PubMedCrossRef
Metadata
Title
Mesh biocompatibility: effects of cellular inflammation and tissue remodelling
Authors
Karsten Junge
Marcel Binnebösel
Klaus T. von Trotha
Raphael Rosch
Uwe Klinge
Ulf P. Neumann
Petra Lynen Jansen
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 2/2012
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0780-0

Other articles of this Issue 2/2012

Langenbeck's Archives of Surgery 2/2012 Go to the issue

Editorial

Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors

Original Article

Comparison of a lightweight polypropylene mesh (Optilene® LP) and a large-pore knitted PTFE mesh (GORE® INFINIT® mesh)—Biocompatibility in a standardized endoscopic extraperitoneal hernia model

Original Article

Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries

Original Article

Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas

Original Article

Adrenocortical carcinoma: effect of hospital volume on patient outcome

Review Article

Inguinal hernia repair: current surgical techniques